Menu

CME Corner

This activity has expired. CME/CE credit is no longer available and the following content may not be available or may not be up-to-date. For a list of current activities that offer CME/CE credit, click here.

Program Detail

Release Date: October-18-07
Credit Expiration Date: April-01-09

Faculty

Manju T Beier, PharmD, FASCP
Senior Partner
Geriatric Consultant Resources LLC
Clinical Associate Professor of Pharmacy
The University of Michigan
Ann Arbor, MI

Phyllis Zee, MD, PhD
Professor
Dept of Neurology
Northwestern University
Feinberg School of Medicine
Chicago, IL

Credit Hours

1

Medium

Online Presentation

Program Description

Insomnia is experienced by over 30% of the adult population at some point in time, and the prevalence of insomnia increases with age. The elderly are often viewed as difficult to treat, but they are among the patients with the greatest need for treatment. As the elderly population grows in this country and the number of long-term care (LTC) residents increases, healthcare professionals working in the LTC sector need to be properly educated on how to best diagnose and treat this common condition. Research indicates that the utilization rates of sleep agents in nursing homes vary dramatically from institution to institution. Hence, there does not appear to be a consistent practice pattern to help guide clinicians, underscoring the need for evidence-based education. This program will present practical strategies that outline how to evaluate and manage insomnia using pharmacologic and nonpharmacologic strategies. The presentation will also address which pharmacologic agents are most appropriate for those with multiple comorbidities.

Program Developer/Facilitator


.

Target Audience

This program has been developed specifically for pharmacists practicing in long-term care, VA pharmacists, geriatric nurses and nurse practitioners, long-term care medical directors, and directors of nursing in long-term care.

Learning Objectives

Upon completion of this educational activity, the participant should be able to:

  1. Discuss ways to recognize those who may be at risk for insomnia
  2. Evaluate barriers that hinder proper diagnosis and management
  3. Outline appropriate behavioral and pharmacologic strategies for treating insomnia in the long-term care setting
  4. Summarize efficacy and safety data for pharmacologic agents approved for the treatment of chronic insomnia
  5. Describe the impact of updates to the State Operations Manual on the management of insomnia in the long-term care facility

Disclosures

It is the policy of ASCP, in accordance with the guidelines set forth by the Accreditation Council for Pharmacy Education, and AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of their continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflict of interest is resolved by ASCP and AKH prior to accreditation of the activity.

The intent of this disclosure is not to prevent a presenter with significant financial interest or other relationship from making the presentation, but rather to provide the audience with information with which they can make their own judgments. It remains for the audience to determine whether the speakers’ interests or relationships may influence the presentation with regard to exposition or conclusion. Faculty are also expected to openly disclose any off-label, experimental, or investigational use of drugs or devices in their presentations.

Dr. Zee discloses that she has been a member of the speaker's bureau for Takeda Pharmaceuticals North America, Inc. and has participated in advisory committees for Boehringer Ingelheim Pharmaceuticals, Inc., Neurocrine Biosciences, Inc., sanofi aventis, and Takeda Pharmaceuticals North America, Inc.

Dr. Beier has no relevant financial relationships to disclose.

This educational activity may contain discussion of published and/or investigational uses of pharmaceutical agents. Some uses of these agents may not have been approved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Credit Statements

Pharmacy Continuing Education: The American Society of Consultant Pharmacists (ASCP) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This program (ACPE # 203-999-07-076-H01-P) was developed by ASCP and is approved for 1.0 Contact Hour (0.1 CEU).

Continuing Medical Education: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of AKH Inc. and Medical Communications Media, Inc. AKH Inc. is accredited by the ACCME to provide continuing medical education for physicians.

AKH Inc. designates this educational activity for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nurse Practitioner Continuing Education: AKH Inc. is accredited by the American Academy of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number 030803. AKH Inc. designates this educational activity for 1 contact hour which includes 0.5 pharmacology hour.

Nursing Continuing Education: NADONA/LTC is an approved provider of continuing nursing education by Georgia Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation #1087. This program provides 1 contact hour by NADONA/LTC.

Participants must successfully complete the post-test (70% or higher) and submit an evaluation to receive credit. A statement of credit will be available immediately if the post-test and evaluation are completed online or mailed within 4-6 weeks if they are sent by mail. This activity will take approximately 60 minutes to complete.

Commercial Support Statements

Supported by an educational grant from Takeda Pharmaceuticals North America, Inc.

Instructions

  1. Click on the "Start program" icon. If you are not already logged in to the site, this will bring you to the login/registration page where you will be able to register as a new cmecorner.com member or check existing registration information. When ready, click on the "Continue to Program" icon at the bottom of the screen.
  2. Complete the short survey and click on "done."
  3. The next screen will permit you to check for or download the Flash player required to run this program and to begin the program presentation. This activity will require approximately 60 minutes to complete.
  4. After the program has finished, click on the "Post-test" button. Complete the short survey and click on "done."
  5. Instructions for completing and submitting the post-test and program evaluation are provided on the post-test screen. A credit certificate will be awarded for a score of 70% or better and may be printed immediately after passing the post-test.

Certificate Fee

$0.00

There is no fee to participate in this program.

Disclaimer

None of the contents may be reproduced in any form without prior written permission from the publisher. The opinions expressed in this program are those of the speakers and do not necessarily reflect the opinions or recommendations of their affiliated institutions, Medical Communications Media, AKH Inc., the American Society of Consultant Pharmacists, the National Association of Directors of Nursing Administration in Long-Term Care, or Takeda Pharmaceuticals North America, Inc. Any medications or other diagnostic or treatment procedures discussed by the program speakers should not be utilized by clinicians without evaluation of their patients’ conditions and possible contraindications or risks, and without a review of any applicable manufacturer’s product information and comparison with the recommendations of other authorities.

By clicking START PROGRAM I acknowledge that I have read the CME/CE information above.

Main Menu
EDITOR'S PICKS